PathoQuest

PathoQuest

Recherche en biotechnologie

A global CRO providing NGS-based Quality Control testing for rapid and safe release of biotherapies to patients.

À propos

PathoQuest is a global CRO providing NGS-based Quality Control testing through its iDTECT® platform of assays for rapid and safe release of biotherapies to patients. Validated and accepted GMP assays for viral safety and genetic characterization of raw materials, cell and gene therapies, mAbs & vaccines. Testing available in Paris (France) and in Wayne PA.

Secteur
Recherche en biotechnologie
Taille de l’entreprise
51-200 employés
Siège social
Paris
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2010
Domaines
Biologics Testing, Biosafety Testing, Biologics Quality Testing, Biologics QC based on Next Generation Sequencing (NGS), Viral Safety, Genetic Characterization, Testing for Clone selection, Genetic Stability Testing, Release Testing for Biologics et Biologics Characterization

Lieux

Employés chez PathoQuest

Nouvelles

Pages similaires

Financement

PathoQuest 6 rounds en tout

Dernier round

Série B

17 391 748,00 $US

Voir plus d’informations sur Crunchbase